Why us?
Ireland’s #1 online healthcare platform
Hair loss is one of the most common concerns for men in Ireland, affecting confidence, self-esteem, and well-being. By age 50, roughly half of Irish men will notice some degree of hair thinning or recession. For many, it starts much earlier, often in their 20s or 30s.
The good news? Male hair loss is highly treatable. Thanks to smartscripts.ie, men can now access Finasteride, an oral medication clinically proven to stop male pattern baldness, through a quick online consultation reviewed by Irish-registered doctors.
This guide explains what causes hair loss, how Finasteride works, and how Irish men can safely and discreetly access effective treatment online.
A secure online assessment — consultation from €20
Genetics (Male Pattern Baldness)
Most male hair loss is caused by androgenetic alopecia, also known as male pattern baldness (MPB).
This hereditary condition is triggered by a sensitivity to dihydrotestosterone (DHT), a hormone derived from testosterone. DHT gradually shrinks hair follicles, producing finer strands until growth stops altogether.
Typical pattern:
Hormones and Health
Hormonal fluctuations, thyroid disorders, or underlying illness can contribute to hair loss. If your hair loss is sudden, patchy, or accompanied by other symptoms
Lifestyle and Stress
Chronic stress, poor diet, smoking, heavy alcohol use, or nutrient deficiencies can all worsen shedding. Short-term stress can cause temporary hair loss known as telogen effluvium, which typically resolves once the cause is treated.
Let’s clear up some common misconceptions:
Hair grows in cycles:
Male pattern baldness happens when DHT shortens the growth phase and shrinks follicles, making new hairs finer until growth stops. Blocking DHT is the key to preventing further loss, and that’s precisely how Finasteride works.
Finasteride is a prescription-only oral tablet that treats male pattern hair loss by reducing DHT levels in the scalp. It belongs to a class of medicines called 5-alpha-reductase inhibitors, which stop testosterone from converting into DHT.
Lowering DHT helps:
Clinical Evidence
Extensive clinical studies show Finasteride reduces hair loss in over 85–90% of men and promotes visible regrowth in most after 3–6 months. Continued use maintains results long term.
With smartscripts.ie, you can access Finasteride safely and discreetly, no GP appointment or waiting list required.
Step-by-Step Process
Every step complies with Irish medical and HPRA regulations, and an Irish doctor approves every prescription.
smartscripts.ie combines clinical reliability with digital convenience, giving Irish men access to genuine treatment, without delay or stigma.
A secure online assessment — consultation from €20
When Will You See Results?
Results vary, but most men notice reduced shedding within 3 months and visible regrowth after 6–9 months. Full benefits are usually seen around 12 months of consistent use.
What Happens If You Stop?
If Finasteride is discontinued, DHT levels rise again and hair loss resumes within a few months. For continued benefit, ongoing use is recommended.
How to Take It
Are There Side Effects?
Finasteride is generally well tolerated and has been used by millions worldwide.
Possible side effects include:
These effects usually resolve after stopping the medicine, and most men experience no issues at all.
If you notice any unusual symptoms, speak with your GP or contact the smartscripts.ie medical team for guidance.
Who Can and Cannot Take Finasteride
Finasteride is suitable for adult men aged 18–65 with male pattern hair loss.
It should not be used by:
Always disclose any other medications you take during your consultation.
A secure online assessment — consultation from €20
Disclaimer: All prescriptions are issued by Irish-registered doctors, subject to clinical suitability. Medication names mentioned are trademarks of their respective owners.
Disclaimer: All medicine names and trademarks are the property of their respective owners. SmartScripts does not claim any affiliation with or endorsement by the trademark holders.
